MoveDMD Trial: Catabasis Provides Update (February 2017) The Catabasis team spoke to our community on February 2, 2017 to discuss what they learned from this latest trial and what comes next in the MoveDMD program. 9 years ago Research & Clinical Trial Webinars,Webinars You may also like Webinar: Staying Safe – Avoiding Falls and Recognizing Signs of Fat Embolism Syndrome (FES) 7 months ago Care Webinars,Webinars Webinar: Neuromuscular Care and Genetic Considerations in Becker 7 months ago Care Webinars,Webinars Becker muscular dystrophy,genetics,neuromuscular care Webinar: Building Protection – Vaccines and Dystrophinopathy 7 months ago Care Webinars,Webinars vaccines Webinar: Understanding BiPAP – Why It’s Needed, What Gets in the Way, and How to Increase Compliance 9 months ago Care Webinars,Webinars bipap Webinar: Capricor – Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy 10 months ago Research & Clinical Trial Webinars,Webinars capricor,cardiac,deramiocel Webinar: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne Muscular Dystrophies 11 months ago Research & Clinical Trial Webinars,Webinars edgewise,sevasemten Webinar: Sarepta Therapeutics – Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne 11 months ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 1:14:53 Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne 11 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 «1234…28»Page 2 of 28